Trial NCT00886743

View at ClinicalTrials.gov 
Org. Study IDs: 3067K1-2213
Secondary IDs: B2491001

Last trial update was posted on 2017-04-19

MeSH Interventions

Oprelvekin

MeSH Conditions

Thrombocytopenia

Other Conditions

Severe Thrombocytopenia

Stopping Reasons

Business reason, Pfizer's requested withdrawal of the Biologics License Application (BLA) . This study is not being discontinued for efficacy or safety reason

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID